285 related articles for article (PubMed ID: 22649023)
21. Chondrosarcoma of bone: a statistical analysis of prognostic factors.
Wang JW; Ger LP; Shih CH; Hsieh MC
J Formos Med Assoc; 1991 Oct; 90(10):998-1003. PubMed ID: 1685183
[TBL] [Abstract][Full Text] [Related]
22. [Tumor prognostic factors in chondrosarcoma of the locomotor system. Apropos of 180 cases].
Ucla E; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1991; 77(5):301-11. PubMed ID: 1836882
[TBL] [Abstract][Full Text] [Related]
23. No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990.
Söderström M; Ekfors TO; Böhling TO; Teppo LH; Vuorio EI; Aro HT
Acta Orthop Scand; 2003 Jun; 74(3):344-50. PubMed ID: 12899557
[TBL] [Abstract][Full Text] [Related]
24. Sinonasal tract chondrosarcoma: 18-year experience at a single institution.
Guo L; Liu J; Sun X; Wang D
Auris Nasus Larynx; 2014 Jun; 41(3):290-3. PubMed ID: 24183859
[TBL] [Abstract][Full Text] [Related]
25. Grade 2 chondrosarcoma: stage I or stage II tumor?
Reith JD; Horodyski MB; Scarborough MT
Clin Orthop Relat Res; 2003 Oct; (415):45-51. PubMed ID: 14612628
[TBL] [Abstract][Full Text] [Related]
26. Is intralesional resection suitable for central grade 1 chondrosarcoma: A systematic review and updated meta-analysis.
Chen X; Yu LJ; Peng HM; Jiang C; Ye CH; Zhu SB; Qian WW
Eur J Surg Oncol; 2017 Sep; 43(9):1718-1726. PubMed ID: 28666625
[TBL] [Abstract][Full Text] [Related]
27. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
28. Chondrosarcoma of bone: an assessment of outcome.
Lee FY; Mankin HJ; Fondren G; Gebhardt MC; Springfield DS; Rosenberg AE; Jennings LC
J Bone Joint Surg Am; 1999 Mar; 81(3):326-38. PubMed ID: 10199270
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathologic diagnosis of de-differentiated chondrosarcoma].
Huang J; Zhang HZ; Zheng L; Zhou J; Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):820-3. PubMed ID: 20193457
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases.
Bergh P; Gunterberg B; Meis-Kindblom JM; Kindblom LG
Cancer; 2001 Apr; 91(7):1201-12. PubMed ID: 11283918
[TBL] [Abstract][Full Text] [Related]
31. High-risk extracranial chondrosarcoma: long-term results of surgery and radiation therapy.
Goda JS; Ferguson PC; O'Sullivan B; Catton CN; Griffin AM; Wunder JS; Bell RS; Kandel RA; Chung PW
Cancer; 2011 Jun; 117(11):2513-9. PubMed ID: 21246520
[TBL] [Abstract][Full Text] [Related]
32. Influence of cryosurgery on treatment outcome of low-grade chondrosarcoma.
Ahlmann ER; Menendez LR; Fedenko AN; Learch T
Clin Orthop Relat Res; 2006 Oct; 451():201-7. PubMed ID: 16788412
[TBL] [Abstract][Full Text] [Related]
33. Long-term Outcome of Chondrosarcoma: A Single Institutional Experience.
Bindiganavile S; Han I; Yun JY; Kim HS
Cancer Res Treat; 2015 Oct; 47(4):897-903. PubMed ID: 25687868
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of Primary and Recurrent Chondrosarcoma of the Rib.
Roos E; van Coevorden F; Verhoef C; Wouters MW; Kroon HM; Hogendoorn PC; van Houdt WJ
Ann Surg Oncol; 2016 Mar; 23(3):811-7. PubMed ID: 26498768
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.
Yin H; Zhou W; Meng J; Zhang D; Wu Z; Wang T; Wang J; Wang P; Shi X; Wu S; Zhao J; Xiao J
Ann Surg Oncol; 2014 Oct; 21(11):3572-8. PubMed ID: 24833099
[TBL] [Abstract][Full Text] [Related]
36. Do pathological fractures influence survival and local recurrence rate in bony sarcomas?
Bramer JA; Abudu AA; Grimer RJ; Carter SR; Tillman RM
Eur J Cancer; 2007 Sep; 43(13):1944-51. PubMed ID: 17698347
[TBL] [Abstract][Full Text] [Related]
37. Survival and prognostic factors in conventional G1 chondrosarcoma.
Fromm J; Klein A; Baur-Melnyk A; Knösel T; Lindner L; Birkenmaier C; Roeder F; Jansson V; Dürr HR
World J Surg Oncol; 2019 Sep; 17(1):155. PubMed ID: 31481076
[TBL] [Abstract][Full Text] [Related]
38. Chondrosarcoma of the scapula: long-term oncologic outcome.
Pant R; Yasko AW; Lewis VO; Raymond K; Lin PP
Cancer; 2005 Jul; 104(1):149-58. PubMed ID: 15895373
[TBL] [Abstract][Full Text] [Related]
39. Survivorship analysis in patients with periosteal chondrosarcoma.
Papagelopoulos PJ; Galanis EC; Mavrogenis AF; Savvidou OD; Bond JR; Unni KK; Sim FH
Clin Orthop Relat Res; 2006 Jul; 448():199-207. PubMed ID: 16826117
[TBL] [Abstract][Full Text] [Related]
40. [Hemipelvectomy for the treatment of high-grade sarcomas: Pronostic of chondrosarcomas compared to other histological types].
Arnal-Burró J; Calvo-Haro JA; Igualada-Blazquez C; Gil-Martínez P; Cuervo-Dehesa M; Vaquero-Martín J
Rev Esp Cir Ortop Traumatol; 2016; 60(1):67-74. PubMed ID: 26091572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
